• Citer

HER2 Positive Breast Cancer: Optimal Management in the (Neo)Adjuvant Setting and Future Perspectives (Invited Speaker).

par Sotiriou, Christos
Référence Academic Meetings organised by the CMA - Chinese International Medical Tribune (July 4-7, 2012: Yangzhou, Hangzhou and Suzhou (Jiangsu province), China)
Publication Non publié, 2012-07

Communication à un colloque

• Détails

Titre:	HER2 Positive Breast Cancer: Optimal Management in the (Neo)Adjuvant Setting and Future Perspectives (Invited Speaker).
Auteur:	Sotiriou, Christos
Informations sur la publication:	Academic Meetings organised by the CMA - Chinese International Medical Tribune (July 4-7, 2012: Yangzhou, Hangzhou and Suzhou (Jiangsu province), China)
Statut de publication:	Non publié, 2012-07
Sujet CREF:	Médecine pathologie humaine
	Cancérologie
	Sciences bio-médicales et agricoles
Langue:	Anglais